Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8231489 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 7 Pages |
Abstract
IMRT-based chemoradiotherapy for anal cancer results in significant reductions in normal tissue dose and acute toxicities versus historic controls treated without IMRT, leading to reduced rates of toxicity-related treatment interruption. Early disease-related outcomes seem encouraging. IMRT is emerging as a standard therapy for anal cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Joseph M. M.D., Christopher G. M.D., Q. Jackie Ph.D., Sua Ph.D., Robert W. B.A., Brian G. M.D.,